BridgeBio Pharma Inc. (BBIO)
NASDAQ
66.50
-0.46 (-0.69%)
Closed
Oct 7, 2026
Day's Range
66.1567.57
52 wk Range
52.7593.42
Price Target - BBIO - BridgeBio Pharma Inc.
Analyst Price Target
Where analysts expect the price to trade over the next twelve months.
Average‪$ 108.43‬
Current‪$ 66.50‬
Low ‪$ 80.00‬High ‪$ 157.00‬
Low‪$ 80.00‬
Average‪$ 108.43‬
Median‪$ 108.00‬
High‪$ 157.00‬
Implied move to the average target: +63.1%
Recommendations - BBIO - BridgeBio Pharma Inc.
Analyst Ratings - BBIO - BridgeBio Pharma Inc.
Analyst ratings
Items per row:
Estimates - BBIO - BridgeBio Pharma Inc.
Estimate momentum
Current quarter · How the consensus estimate has moved over the last 90 days.
90 days ago-0.50
Now-0.60
Change-22.0%
Revised last month1/1
Growth estimates
Current quarter+38.7%
Next quarter+43.6%
Current year+29.0%
Next year+105.7%
Next 5 years (per year)+53.1%
Past 5 years (per year)+3.4%
EPS estimates
Earnings History - BBIO - BridgeBio Pharma Inc.
Estimate surprises
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
